Medicare Procedure and Patient Information
2023 Medicare Patient Data
Information about Medicare patients treated by Dr. Christopher Ballantyne, MD.
| Male | |
|---|---|
| Female |
(No ratings)
Dr. Christopher Ballantyne, MD is an urologist in Greenville, SC specializing in urology (urinary tract disease). He graduated from Mercer University School of Medicine in 2017 and has 9 years of experience. Dr. Christopher Ballantyne, MD is affiliated with Bon Secours and Bon Secours St. Francis.
Click on any procedure below to see further details on volume and pricing among Medicare patients.
In 2024, Dr. Christopher Ballantyne, MD had a list price for laser prostate surgery, minimally invasive prostate procedures, minimally invasive prostate surgery, prostate ablation, and prostate surgery that was lower than the list prices billed to Medicare by 95% of providers in related specialties within South Carolina. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.
In 2024, Dr. Christopher Ballantyne, MD had a list price for urologic surgery that was lower than the list prices billed to Medicare by 90% of providers in related specialties within South Carolina. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.
In 2012, among providers in related specialties within South Carolina, Dr. Christopher Ballantyne, MD performed more laser prostate surgery procedures for Medicare patients than 75% of them and he also had a list price for ablation, and minimally invasive surgery that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.
Information about Medicare patients treated by Dr. Christopher Ballantyne, MD.
| Male | 12 |
|---|---|
| Female | 0 |
The top procedures that Dr. Christopher Ballantyne, MD treated as an urologist in Greenville, SC during 2024 were urologic procedures, minimally invasive procedures, laser treatment and ablation.
Volume of procedures performed by Dr. Christopher Ballantyne, MD for Medicare patients.
| ablation | 23 |
|---|---|
| laser treatment | 23 |
| minimally invasive procedures | 23 |
| urologic procedures | 56 |
Information about Medicare patients treated by Dr. Christopher Ballantyne, MD.
| From 65 to 74 | 36 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
| Hypertension | 75 |
|---|---|
| High Cholesterol | 75 |
| Stroke | 0 |
| Ischemic Heart Disease | 33 |
| Depression | 0 |
| Chronic Kidney Disease | 38 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 18 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 21 |
| Dementia | 0 |
| Cancer | 35 |
Volume of procedures performed by Dr. Christopher Ballantyne, MD for Medicare patients.
The highest averages for the top procedures that Dr. Christopher Ballantyne, MD treated as an urologist in Greenville, SC were urologic procedures, minimally invasive procedures, laser treatment and ablation.
| ablation | 23 |
|---|---|
| laser treatment | 23 |
| minimally invasive procedures | 23 |
| urologic procedures | 56 |
Information about Medicare patients treated by Dr. Christopher Ballantyne, MD.
| Male | 6 |
|---|---|
| Female | 0 |
| 75 to 84 | 0 |
|---|---|
| 85 and over | 0 |
| Less than 65 | 0 |
| 65 to 74 | 18 |
The highest averages of the most common conditions of Medicare patients that Dr. Christopher Ballantyne, MD treated were high cholesterol, hypertension, cancer and chronic kidney disease.
| Hypertension | 37 |
|---|---|
| High Cholesterol | 37 |
| Stroke | 0 |
| Ischemic Heart Disease | 16 |
| Depression | 0 |
| Chronic Kidney Disease | 19 |
| Asthma | 0 |
| Osteoporosis | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 10 |
| Atrial Fibrillation | 9 |
| Cancer | 17 |
| Dementia | 0 |
Dr. Christopher Ballantyne, MD graduated from Mercer University School of Medicine in 2017. He completed residency at University of Virginia Affiliated Hospitals. He has a state license in Arizona.
Medical School: Mercer University School of Medicine (2017)
Residency: University of Virginia Affiliated Hospitals (2023)
Licensed In: Arizona
Dr. Christopher Ballantyne, MD is associated with these hospitals and organizations:
Dr. Christopher Ballantyne, MD appears to accept the following insurance providers: CorVel, WellCare, Medicare Advantage, MultiPlan, United Healthcare, Medicaid, Humana, Cigna, Anthem, WellPoint, Molina Healthcare, Payer Provider, Sedgwick/Careworks KY OH SC VA, America's 1st Choice SC, Absolute Total Care SC, Medicare SC, Aetna Health Insurance Company SC, Medcost SC, Select Health Network SC, CIN - Health Partners Bon Secours St. Francis (Greenvillle), Blue Cross Blue Shield SC, OMC (Oscar Mgmt) OH KY SC VA and Employer Health Network SC.
According to our sources, Dr. Christopher Ballantyne, MD accepts the following insurance providers:
Dr. Christopher Ballantyne, MD does not have any reviews yet, be the first to leave a review of Dr. Christopher Ballantyne, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Christopher Ballantyne, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Boston Scientific Corporation |
$35,394
AMS 700 $226 |
LITHOCLAST $129 |
LITHOVUE $19 |
$35,020 |
|---|---|---|---|---|
| Progenics Pharmaceuticals, Inc. |
$125
PYLARIFY $125 |
|||
| KARL STORZ Endoscopy-America |
$105
Flex-X $105 |
|||
| Endo Pharmaceuticals Inc. |
$82
XIAFLEX $82 |
|||
| Medtronic USA, Inc. |
$74
INTERSTIM ICON $74 |
|||
| Other |
$160
Axonics $61 |
INTERSTIM $45 |
NCircle $28 |
OXLUMO $26 |
| Grant | $35,000 |
|---|---|
| Food and Beverage | $939 |
Dr. Christopher Ballantyne is a physician who specializes in urology (urinary tract disease). He is affiliated with Bon Secours. Dr. Ballantyne accepts Anthem, Blue California, and CorVel, in addition to other insurance carriers. Before completing his residency at a hospital affiliated with the University of Virginia, Dr. Ballantyne attended medical school at Mercer University School of Medicine.